Forecyte Bio is a CDMO founded in 2021 to serve the rapidly growing cell and gene therapy industry. The company's team comprises industry experts with decades of experience in cell and gene therapy CMC processes and offers clients a one-stop holistic package from early concept through IND filing and commercial licensure and manufacturing. Some of their services include GMP production, CMC documentation for IND and BLA, plasmid production, viral vector production, and cell processing. The company has facilities in both the United States and China.